Patent · US Active

Microphthalmia-associated transcription factor-derived peptide and composition containing same

US9493528B2 · kind B2 · utility

0Cited by
2References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 7, 2014
Grant dateNov 15, 2016
Priority date
Expiry dateJan 7, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are small peptide fragments derived from microphthalmia-associated transcription factor (MITF) and a method for preventing or treating melanoma using the same as an active ingredient. Further provided is a method for skin-whitening and/or for inhibiting skin pigmentation, using the peptide fragments as an active ingredient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.